2026:
Antipsychotic deprescribing as a problem of care, not compliance: Helene Speyer, Marte Ustrup, Mette Ødegaard, Schizophrenia (Heidelb). 2026 Apr 21. doi: 10.1038/s41537-026-00745-y. Online ahead of print.
Metabolic parameters as a predictor of relapse in patients with schizophrenia undergoing tapering of antipsychotics: Sofie Norlin Mølgaard, Alexander Nøstdal, Jimmi Nielsen, Mette Ødegaard Nielsen, J Psychiatr Res, 2026 Mar 11:197:294-297. doi: 10.1016/j.jpsychires.2026.03.014.
Kickan Roed, Julie Midtgaard, Jimmi Nielsen, Ingrid Egerod, Mette Ødegaard, Niels Buus,
Soc Sci Med.,2026, May:397:119134. doi: 10.1016/j.socscimed.2026.119134.
2025:
Milo Wolfgang Pilgaard Kristensen, Bahast Biuk, Jimmi Nielsen, Kirsten Borup Bojesen, Mette Ødegaard Nielsen, Behav Brain Res, 2025, Feb 28:479:115338. doi: 10.1016/j.bbr.2024.115338.
Asenapine-induced severe dystonia in a patient with schizophrenia: medication error due to sound-alike drug: Wulff S, Nielsen J, Pedersen N, Nielsen MØ.BMJ Case Rep. 2025 Jun 24;18(6):e264354. doi: 10.1136/bcr-2024-264354.PMID: 40555536
Antipsykotika i kombination med centralstimulatia: Martin Jacobsen, Niels August Willer Strand, Søren Bøgevig, Jimmi Nielsen. Ugeskrift for læger, 2025; Nov 3; 187(45).
Clozapine acceptance and refusal rates for inpatients vs. outpatients with schizophrenia- secondary analyses of real-world data from a Danish quality assurance and improvement audit: Michelle Iris Jakobsen, Jimmi Nielsen. PMID: 40336324 DOI: 10.1080/08039488.2025.2499587
What is the current scope of research assessing patients' and clinicians' perspectives on clozapine treatment? A comprehensive scoping review: Michelle Iris Jakobsen, Julie Perrine Schaug, Ole Jakob Storebø, Stephen F Austin, Jimmi Nielsen, Erik Simonsen. PMID: 39819922 PMCID: PMC11751990 DOI: 10.1136/bmjopen-2024-085956
Perspectives of clozapine-naïve outpatients with treatment-resistant schizophrenia on clozapine commencement: a mixed-methods convergent study: Michelle Iris Jakobsen, Stephen F Austin, Ole Jakob Storebø, Erik Simonsen, Jimmi Nielsen. PMID: 40107686 PMCID: PMC12001365 DOI: 10.1136/bmjopen-2024-093394
2024:
Clinical considerations and pitfalls in the use of depot antipsychotics [Article in Danish]: Niels August Willer Strand, Mette Ødegaard Nielsen, Jimmi Nielsen. Ugeskr Laeger. 2024 May 13;186(20):V12230776. doi: 10.61409/V12230776.
Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose Reduction:Motivational factors and previous experiences in patients with schizophrenia seeking guided antipsychotic dose-reduction: A. Nøstdal, R. Hilker, J. Nielsen, MØ Nielsen. Psychiatric Services, Nov 1, 75(11), 2024.
Glutamate, GABA and NAA in treatment-resistant schizophrenia: a systematic review of the effect of clozapine and group differences between clozapine-responders and non-responders: M. Kristensen, B. Biuk, J. Nielsen, K. Bojesen, M. Ø. Nielsen. Behavioural Brain Research, 2024.
Clinical experiences of guided tapering of antipsychotics for patients with schizophrenia- a case series: Sofie Norlin Mølgaard, Mette Ødegaard Nielsen, Kickan Roed, Jimmi Nielsen. BMC Psychiatry. 2024 Mar 29;24(1):240. doi: 10.1186/s12888-024-05699-y.
Motivations for and Experiences With Antipsychotic Tapering Among Patients With Schizophrenia Seeking Guided Dose Reduction: A. Nøstdal, R. Hilker, J. Nielsen, MØ Nielsen. Psychiatric Services, 2024 (75):11 p 1117-1124
2023:
Mental health staff's perspectives on tapering of antipsychotic medication: a focus group study: Roed, N. Buus, J. Nielsen, P. Christensen, J. Midtgaard. Qualitative Health Research, 2023, (33), p1165-1176
Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians' perspectives: Michelle Iris Jakobsen, Stephen Fitzgerald Austin, Ole Jakob Storebø, Jimmi Nielsen, Erik Simonsen. Simonsen. PMID: 38135678 PMCID: PMC10746712 DOI: 10.1038/s41537-023-00423-3
Antipsychotic prescribing practices for outpatients with schizophrenia and reasons for non-clozapine treatment - Data from a Danish quality assessment audit: Michelle I Jakobsen, Julie P Schaug, Jimmi Nielsen, Erik Simonsen. PMID: 36651766 DOI: 10.1080/08039488.2022.2160878
Alterations in inflammatory markers after a 12-week exercise program in individuals with schizophrenia-a randomized controlled trial: Therese Torgersen Bigseth, John Abel Engh, Eivind Andersen, Gry Bang-Kittilsen, Jens Egeland, Ragnhild Sørum Falk, Tom Langerud Holmen, Jon Mordal, Jimmi Nielsen, Thor Ueland, Torkel Vang, Mats Fredriksen. PMID: 37265560 PMCID: PMC10231033 DOI: 10.3389/fpsyt.2023.1175171